According to the World Health Organization (WHO), in 2019, there were approximately 229 million cases of malaria around the world, of which 409,000 were fatal. Now, researchers at the Francis Crick ...

New research found that inflammation in the body can slow down the development of malaria parasites in the bloodstream -- a discovery that may constitute a potential new strategy for preventing or ...

Scientists from the Universities of Leicester and Nottingham have received nearly £600,000 to research how sexual development and gene shuffling within the malaria parasite could help to control ...

Please provide your email address to receive an email when new articles are posted on . Researchers said they have identified a new “hidden” life cycle of malaria parasites in the human spleen — a ...

Malaria is a pernicious public health problem in many areas of the world. Sub-Saharan Africa, where cases recorded represent over 90% of the world total, is particularly badly hit. Modelling by IRD ...

Researchers have designed a drug-like compound which effectively blocks a critical step in the malaria parasite life cycle and are working to develop this compound into a potential first of its kind ...

Malaria is a life-threatening disease that is transferred by mosquito bites. Interestingly, a specific type of mosquito can carry the disease. The transfer of the parasite to humans travels to the ...

A microbe that is transmitted between male and female mosquitoes but can also block reproduction could be key to controlling malaria by targeting its release into mosquito populations, a study says.

In this new study, published in PLOS Biology, scientists have uncovered the crucial roles of a group of motor proteins named kinesins during the parasite life cycle. The research, led by Rita Tewari, ...

WEHI researchers have visualised a key protein complex in malaria parasites for the first time, uncovering a new target for next-generation vaccines that could help stop the disease from spreading.

Malaria vaccine shows over 50% efficacy in adults following controlled human malaria infection, supporting further trials in children.